The RUBIUS THERAPEUTICS brand, founded in 2013 (United States), from 2214 competing brands. RUBIUS THERAPEUTICS is owned by RUBIUS THERAPEUTICS, listed on the stock exchange of Etats-Unis RUBIUS THERAPEUTICS is part of the Biotechnology activity sector.